Nina Zimmermann
- Economics and Econometrics top 5%
- Pharmacology top 5%
- General Health Professions
- Pediatrics, Perinatology and Child Health
- Immunology
- Co-authors
- Sabine VoglerKees de JoncheereChristine LeopoldClaudia HablAnna BucsicsJutta PiessneggerZaheer‐Ud‐Din BabarPeter A. Schneider
- Topics
- Pharmaceutical Economics and Policy (33 papers)Health Systems, Economic Evaluations, Quality of Life (25 papers)Pharmaceutical industry and healthcare (7 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEValue in Health
- Partner nations
- AustriaUnited StatesNew Zealand
In The Last Decade
Nina Zimmermann
36 papers receiving 382 citations
Peers
Comparison fields: 5 of 62
- Economics and Econometrics 341
- Pharmacology 87
- General Health Professions 68
- Pediatrics, Perinatology and Child Health 55
- Immunology 50
Countries citing papers authored by Nina Zimmermann
This map shows the geographic impact of Nina Zimmermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Zimmermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Zimmermann more than expected).
Fields of papers citing papers by Nina Zimmermann
This network shows the impact of papers produced by Nina Zimmermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Zimmermann. The network helps show where Nina Zimmermann may publish in the future.
Co-authorship network of co-authors of Nina Zimmermann
This figure shows the co-authorship network connecting the top 25 collaborators of Nina Zimmermann. A scholar is included among the top collaborators of Nina Zimmermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Zimmermann. Nina Zimmermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 6 | |
| 4 | Evaluation of the Affordable Medicines Programme in Ukraine | 2 |
| 5 | 21 | |
| 6 | 8 | |
| 7 | 4 | |
| 8 | 32 | |
| 9 | Preisvergleich kostenintensiver Arzneimittel 2015 | 1 |
| 10 | 1 | |
| 11 | Challenges and opportunities for pharmaceutical pricing and reimbursement policies | 1 |
| 12 | 2 | |
| 13 | Study of the policy mix for the reimbursement of medicinalproducts. Proposal for a best practice-based approachbased on stakeholder assessment | 6 |
| 14 | 16 | |
| 15 | 1 | |
| 16 | 2 | |
| 17 | 1 | |
| 18 | 106 | |
| 19 | 6 | |
| 20 | 1 |
About Nina Zimmermann
Nina Zimmermann is a scholar working on Economics and Econometrics, Pharmacology and Geriatrics and Gerontology, having authored 38 papers that have together received 401 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (33 papers), Health Systems, Economic Evaluations, Quality of Life (25 papers) and Pharmaceutical industry and healthcare (7 papers). The work is most often cited by research in Economics and Econometrics (341 citations), Pharmacology (87 citations) and Family Practice (18 citations). Nina Zimmermann has collaborated with scholars based in Austria, United States and New Zealand. Frequent co-authors include Sabine Vogler, Kees de Joncheere, Christine Leopold, Claudia Habl, Anna Bucsics, Jutta Piessnegger, Zaheer‐Ud‐Din Babar, Peter A. Schneider, Veronika J. Wirtz and Alessandra Ferrario. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.